Coadministration of a SMN2 exon 7 splice-correcting oligonucleotide and RG7800–a small molecule that promotes exon 7 inclusion–provided more pronounced additive effects in SMA mice (134). Here, SMN2 is linked to proximal spinal muscular atrophy.